Jump to content

Global Virome Project

From Wikipedia, the free encyclopedia

The Global Virome Project (GVP) is an American-led international collaborative research initiative based at the One Health Institute at the University of California, Davis.[1][2] The project was co-launched by EcoHealth Alliance president Peter Daszak, Nathan Wolfe and Edward Rubin of Metabiota, and former Chinese Center for Disease Control and Prevention director George F. Gao.[3]

The goal of the Global Virome Project (GVP) is to identify and prevent future virus outbreaks.[4] The GVP is centered on the massive collection and sequencing of the planet's unknown viruses, with an estimated 1.6 million viral species yet to be discovered in mammal and bird populations. Of these, 631,000 to 827,000 have zoonotic potential.[4] The cost of identifying these unidentified viruses is a major limitation of the GVP, with a total cost estimate of $1.2 billion. That being said, preventing an outbreak is still less costly than reacting to one, with the total estimated cost of the ongoing COVID-19 pandemic estimated at more than $16 trillion.[5] The Global Virome project also aims to boost infectious disease surveillance around the globe by using low cost sequencing methods in high risk countries to prevent disease outbreaks by expanding on the efforts of the USAID (agency for international development) EPT (Emerging Pandemic Threats) PREDICT project. The PREDICT project was founded to discover unidentified viral species by sampling animals and humans in countries with high zoonotic disease threat and determine the mechanisms that cause viral spillover into human populations. The Predict project found over 1000 unique viruses in animals and humans.[6]

The Global Virome Project could aid in pandemic surveillance, diagnosis techniques and prevention strategies, and determine the need for pre-emptive production of vaccine and other countermeasures for candidate high-risk viruses. The GVP can also provide further insights into viral pathogenicity and possible biosecurity methods in agriculture.[3]

The Global Virome Project was supposed to be begin sampling wild animal populations in 2020 but were delayed due to the COVID-19 pandemic.[7]

References

[edit]
  1. ^ Vernimmen, Tim (2020-04-16). "Infectious disease: Making — and breaking — the animal connection". Knowable Magazine. doi:10.1146/knowable-041620-1. S2CID 218810265.
  2. ^ "Contact". Global Virome Project. Archived from the original on 2022-08-22. Retrieved 2022-08-22.
  3. ^ a b Carroll, Dennis; Daszak, Peter; Wolfe, Nathan D.; Gao, George F.; Morel, Carlos M.; Morzaria, Subhash; Pablos-Méndez, Ariel; Tomori, Oyewale; Mazet, Jonna A. K. (2018-02-23). "The Global Virome Project". Science. 359 (6378): 872–874. Bibcode:2018Sci...359..872C. doi:10.1126/science.aap7463. ISSN 0036-8075. PMID 29472471. S2CID 3543474.
  4. ^ a b "Ambitious Global Virome Project Could Mark End of Pandemic Era". 22 February 2018.
  5. ^ Zhang, Peter (2021-07-09). "Reproduction of 'The COVID-19 Pandemic and the $16 Trillion Virus'". JAMA. doi:10.48152/ssrp-c638-xc85.
  6. ^ Schmidt, Charles (2018-10-11). "The virome hunters". Nature Biotechnology. 36 (10): 916–919. doi:10.1038/nbt.4268. ISSN 1087-0156. PMC 7097093. PMID 30307913.
  7. ^ "Before the Next Pandemic, an Ambitious Push to Catalog Viruses in Wildlife".